Celal Bayar University School of Medicine, Turkey
Tevfik Guvenal Is graduated from Cumhuriyet University School of Medicine in 1989.Istanbul Goztepe Training and Research Hospital specialist started education in 1995. did military service as an obstetrician in Eskisehir Air Hospital.Cumhuriyet University Faculty of Medicine Department of Obstetrics and Gynecology in 1999 started Department in academic life. In 2000 Hacettepe University Obstetrics and Gynecology, Gynecologic Oncology, received training in the field. In 2003 became a professor in 2009 and since 2009 Celal Bayar University Department of Obstetrics and Gynecology, Gynecologic Oncology have been working as a responsible unit. Pelvic and vaginal surgery is my area of special interest outside of Gynecologic Oncology.Board member of the Turkish Association of Gynecologic Oncology Gynecologic Oncology, Journal of Turkish and have been responsible for writing duties as chief.
Objective. The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary surgery, surgical staging and the extensiveness of staging. Methods. In a retrospective Turkishmulticenter study, 539 patients, from14 institutions,with borderline ovarian tumors were investigated. Some of the demographic, clinical and surgical characteristics of the cases were evaluated. The effects of type of surgery, surgical staging; complete or incomplete staging on survival rates were calculated by using Kaplan–Meier method. Results. The median age at diagnosis was 40 years (range 15–84) and 71.1% of patients were premenopausal. The most common histologic types were serous and mucinous. Majority of the staged cases were in Stage IA (73.5%). 242 patients underwent conservative surgery. Recurrence rates were significantly higher in conservative surgery group (8.3% vs. 3%). Of all patients in this study, 294 (54.5%) have undergone surgical staging procedures. Of the patientswho underwent surgical staging, 228 (77.6%) had comprehensive staging including lymphadenectomy. Appendectomy was performed on 204 (37.8%) of the patients. The median follow-up time was 36 months (range 1–120 months). Five-year survival rate was 100% and median survival time was 120 months. Surgical staging, lymph node sampling or dissection and appendectomy didn't cause any difference on survival. Conclusion. Comprehensive surgical staging, lymph node sampling or dissection and appendectomy are not beneficial in borderline ovarian tumors surgical management